Because romidepsin increased the expression of PD-L1 in colon cancer cells, we next evaluated the influence of romidepsin on T cells, which was mediated by crosstalk between cancer cells and T cells through PD-L1/PD-1 signaling. Here, CD274 is linked to cancer.